New food ingredient BP-CBB put to the test in first human study

NCT ID NCT07628608

Recruiting now Knowledge-focused Sponsor: Bactolife A/S Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is the first time a new food ingredient, BP-CBB, is being tested in people. The goal is to check its safety and how well people tolerate taking it once a day. Sixty healthy adults aged 18 to 65 will take either BP-CBB or a placebo for a period of time. This study does not aim to treat or cure any disease, but to gather information for future research.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SAFETY AND TOLERABILITY IN HEALTHY VOLUNTEERS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

SAFETY AND TOLERABILITY IN HEALTHY VOLUNTEERS

Contacts and locations

Locations

Atlantia Clinical Trials
RECRUITING

Cork, T23 R50R, Ireland

More trials for these conditions

Other studies related to the condition(s) this trial covers.